PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.70
Ask: 3.80
Change: 0.00 (0.00%)
Spread: 0.10 (2.703%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.75
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

Wed, 28th Jun 2023 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News:

----------

All Things Considered Group PLC - London-based music firm providing talent management, live booking and livestreaming - Intends to raise GBP4 million through a placing and subscription for shares at 92.5 pence each. Proceeds will be used primarily to buy a 60% holding in Sandbag Ltd, a full-service merchandise company for GBP2.4 million, and provide capital for future accretive opportunities. Expects deal to be earnings accretive and mark a substantial addition to the group's client base.

----------

T42 IOT Tracking Solutions PLC - Jersey-based real-time tracking, security, and monitoring solutions provider - Reports revenue in year to December 31, 2022 of USD4.0 million, down 2.4% from USD4.1 million, the year prior. Pretax loss narrows to USD1.0 million from USD3.0 million. Sees a continuation of post-Covid and supply chain issues that have impacted performance, despite several successful trials of its technology by potential customers. Also experiences delays in the anticipated substantial orders from its Latin America distributor. Targeting a significant improvement in revenue and gross margins in the rest of 2023.

----------

Xpediator PLC - Braintree, England-based freight management services provider - Expects court sanction hearing to approve the scheme facilitating the takeover by funds advised by BaltCap, Cogels Investments Ltd and Nuoma IR Kapitalas to take place next week Thursday. Shares in Xpediator expected to be cancelled on July 10.

----------

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says all resolutions except special resolutions 12 and 13, concerning disapplication of statutory pre-emption rights for allowing issue of shares for cash and share options, were passed.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 May 2024 12:00

LONDON MARKET MIDDAY: FTSE 100 hits record high on BoE vote, UK GDP

(Alliance News) - Stock prices in London were up at midday on Friday, hitting a record high once again as investors reacted positively to a dovish Bank of England interest rates hold.

Read more
10 May 2024 11:57

Polarean shares jump on MRI system order

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging shares were surging on Friday, after receiving its second de novo order for a new Xenon MRI System from the University of Alabama at Birmingham (UAB) Hospital.

Read more
10 May 2024 11:40

Polarean shares soar on University of Alabama deal for Xenon MRI

(Alliance News) - Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital in the US.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 15:40

IN BRIEF: Polarean Imaging wins order for new polariser

Polarean Imaging PLC - London-based medical imaging technology developer - Receives an order for a new polariser to replace the research polariser at Cincinnati Children's Hospital Medical Center. "Cincinnati Children's previously purchased the first clinical polariser and continues to demonstrate a commitment to the future of Xenon MRI for challenging lung diseases. Cincinnati Children's performs hospital clinical imaging on both children and adults (from their neighbouring partner institution, UC Medical Centre)," Polarean says.

Read more
3 May 2024 11:46

Polarean gets new polariser order from Cincinnati Children's

(Sharecast News) - Polarean Imaging announced a new polariser order to replace the research polariser at Cincinnati Children's Hospital Medical Center on Friday.

Read more
16 Apr 2024 20:16

TRADING UPDATES: Nexteq confident of meeting full-year expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:28

Polarean Imaging shares sink after announcing a costly strategic plan

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions.

Read more
15 Jan 2024 11:21

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Read more
7 Dec 2023 16:01

Polarean gets first de novo order for Xenoview polariser

(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.

Read more
7 Dec 2023 12:14

IN BRIEF: Polarean shares jump on Xenoview polariser order

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year.

Read more
7 Dec 2023 11:11

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Sep 2023 14:12

Polarean Imaging enters strategic partnership with VIDA Diagnostics

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.

Read more
8 Sep 2023 10:27

Polarean Imaging partners with Vida Diagnostics on MRI solutions

(Alliance News) - Polarean Imaging PLC on Friday said that it has partnered with Vida Diagnostics Inc to work on advanced magnetic resonance imaging solutions for the lungs.

Read more
7 Sep 2023 14:26

TRADING UPDATES: Polarean withdraws commercial targets on revenue drop

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.